Business
Notice of Allowance of TMT1 Patent in Canada
Notice of Allowance of TMT1 Patent in Canada.
About this update from Proteome Sciences Plc
[{"type":"text","content":"\n \nPROTEOME SCIENCES plc\n\nNotice of Allowance of TMT1 Patent in Canada\n\n8 May 2007. Proteome Sciences plc (\"Proteome Sciences\") is pleased to announce\nthat it has received the Notice of Allowance for Canadian Patent Application\nNo. 2,403,114 entitled \"Mass Markers\" dated 13th April, 2007 (\"TMT1\"). TMT1 is\nthe first patent filed describing isobaric mass tags and is part of a series of\npatents including TMT2 in Canada that was granted on 21st November, 2006. TMT1\nhas established a broad set of claims controlling the field of isobaric tandem\nmass tagging (Tandem Mass Tags® and TMT®) whilst TMT2 relates to more specific\nisobaric mass tag structures and various methods of use. The two patents are\nhighly complementary, but TMT1, with its early priority and broader claims, is\nof greater significance.\n\nThe TMT1 Notice of Allowance is very important for Proteome Sciences because it\nwill enable the company for the first time to approach entities using isobaric\nmass labels in Canada and to alert them that they can obtain licences from\nProteome Sciences for the manufacture or use of any type of isobaric mass tags\nin their research programmes. Such licenses will allow revenue to be generated\nfrom any applications in the field of isobaric mass tagging.\n\nCommenting on the Notice of Allowance Christopher Pearce, Chief Executive of\nProteome Sciences said:\n\n\"We are delighted that our first full set of patents covering isobaric tandem\nmass tagging (TMT®) have been allowed in Canada. This should be followed up\nshortly with similar allowances in Europe and the USA.\n\nIn Europe, the patent process for TMT1 is nearly completed with the Rule 51(4)\nNotice of Intention to Grant having been published and the patent expected to\nbe issued in the near future. In the USA, the TMT1 and TMT2 patent applications\nare in the final stages of processing and we anticipate that these too will be\nconcluded shortly.\n\nHaving acquired the TMT® technology in 2002, Proteome Sciences was provided\nwith both the earliest date of invention of isobaric mass tagging and the\npatents for the technology. Our goal is to have a full range of TMT® products\nlaunched in the market in the second half of the year. These have been\ndeveloped in-house over the last year and, with the issuance of the patents and\nthe completion of the licensi...